RTX vs VXRT · P/E 36, rev $88.60B vs rev $28.7M
RTX Corporation (RTX) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the RTX and VXRT stock pages for the full models.
Not investment advice.